NYSE$OHI

Omega Healthcare Investors Inc · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

Omega Healthcare's performance was impacted by operator restructurings and asset sales, but also benefited from new investments and Medicaid reimbursement rate increases.

Omega Healthcare Investors reported a net income of $105.1 million for the quarter ended September 30, 2022, a decrease of $37.8 million compared to the same period in 2021. Revenues totaled $239.4 million, a decrease of $42.2 million over the same period in 2021. The decrease primarily resulted from asset sales, operator restructurings, and no rental income from Agemo Holdings, LLC.

  • Net income for the quarter was $105 million, or $0.43 per common share.
  • Nareit Funds From Operations (FFO) for the quarter was $159 million, or $0.65 per common share.
  • Adjusted Funds From Operations (AFFO) for the quarter was $185 million, or $0.76 per common share.
  • Completed $28 million in real estate acquisitions and invested $40 million in a new loan.

Headline financials

Total Revenue

$239M

Previous: $282M-15.0%
EPS (adj)

$0.76

Previous: $0.85-10.6%
Capital Expenditures

-$192M

Previous: -$737M+74.0%
Free Cash Flow

-$86.8M

Previous: -$594M+85.4%
Net Income

$105M

Previous: $143M-26.4%
Operating Income

$61.8M

Previous: $62M-0.4%
Gross Profit

$239M

Previous: $256M-6.5%
Cash & Equivalents

$135M

Previous: $103M+31.4%
Total Assets

$9.48B

Previous: $9.78B-3.1%
Stock-Based Comp

$6.81M

Previous: $5.71M+19.3%

Revenue & EPS history

Omega Healthcare · Revenue · Quarterly

$239M

Q3 2022-15%vs Q3 2021
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Omega Healthcare · $283M total across 3 segments · Q2 2025

  • Rental income
    $239M
  • Interest income
    $43M
  • Miscellaneous income
    $307K

Forward guidance

Omega Healthcare anticipates that resuming lease payments from restructured operators and repurposed proceeds from asset sales will enhance dividend coverage and leverage metrics by early next year.

Tailwinds

  • Expects combination of resuming lease payments from restructured operators.
  • Expects repurposed proceeds from asset sales to be reflected in adjusted FFO and FAD.
  • Anticipates further enhancement of dividend coverage.
  • Anticipates further enhancement of leverage metrics.
  • Believes skilled nursing industry is well positioned to benefit from multi-decade demographic tailwinds.

Headwinds

  • Occupancy continues to slowly improve.
  • Many states have implemented strong Medicaid reimbursement rate increases.
  • Occupancy still not having fully returned.
  • Operators struggling with a higher cost environment.
  • Near-term risk of further operator issues remains elevated.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

-0.1%

Avg return

Earnings day

+0.2%

Avg return

5 days after

+2.4%

Avg return

30 days after

49%

33 / 68 earnings

Positive

+13.1%

Q1 2022

Best reaction

-9.1%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026-0.0%-2.6%-1.3%
Q4 2025+6.1%+5.8%+11.0%
Q3 2025+5.3%+7.9%+15.2%
Q1 2025-4.1%-7.5%-4.0%
Q4 2024-0.7%-6.0%-3.7%
Q3 2024+1.4%-4.5%-3.0%
Q2 2024+5.1%+1.8%+8.6%
Q1 2024+2.1%+0.8%+5.3%
Q4 2023+6.9%+10.2%+9.9%
Q3 2023-5.2%-5.8%-3.4%
Q2 2023-1.1%+1.0%+3.2%
Q1 2023+8.5%+7.9%+10.4%
Q4 2022-2.2%-5.1%-7.9%
Q3 2022-1.3%+2.5%-5.1%
Q2 2022+1.8%+3.2%+5.4%
Q1 2022+13.1%+11.3%+15.9%
Q4 2021-8.4%-11.2%-8.7%
Q3 2021+0.2%-4.7%-7.6%
Q2 2021-4.6%-3.2%-6.9%
Q1 2021-2.0%-3.9%-0.1%
Q4 2020-0.6%-1.2%+1.2%
Q3 2020-1.1%+3.8%+23.1%
Q2 2020+3.0%+4.8%-0.2%
Q1 2020+0.0%+1.8%+21.9%
Q4 2019-0.0%+1.4%-7.7%
Q3 2019-2.2%-5.4%-2.6%
Q2 2019+1.5%+7.8%+15.4%
Q1 2019+1.5%+4.3%+2.3%
Q4 2018-5.9%-6.9%-6.5%
Q3 2018+5.2%+7.5%+15.6%
Q2 2018+3.7%+5.5%+10.9%
Q1 2018+3.4%+7.0%+13.1%
Q4 2017-2.9%+1.4%+3.7%
Q3 2017-9.1%-10.6%-15.6%
Q2 2017-3.4%-4.9%-5.8%
Q1 2017-2.6%-0.8%-3.3%
Q4 2016-5.0%-1.8%-3.7%
Q3 2016-1.7%-6.5%-5.8%
Q2 2016+1.5%+1.9%+3.5%
Q1 2016-1.2%
Q4 2015+4.4%
Q3 2015-0.5%
Q2 2015+1.2%
Q1 2015-3.5%
Q4 2014-0.7%
Q3 2014+1.8%
Q2 2014+0.1%
Q1 2014-0.6%
Q4 2013-1.4%
Q3 2013-2.0%
Q2 2013-7.3%
Q1 2013+0.5%
Q4 2012+4.2%
Q3 2012-3.0%
Q2 2012+1.1%
Q1 2012+0.4%
Q4 2011-1.8%
Q3 2011+2.2%
Q2 2011+3.2%
Q1 2010+0.1%
Q1 2011+1.3%
Q4 2008-2.2%
Q4 2010-2.2%
Q3 2010-4.4%
Q3 2009-4.4%
Q2 2009+1.3%
Q2 2010+1.3%
Q4 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro